Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Non-steroidal Anti-Inflammatory Drugs Market
The Non-steroidal Anti-Inflammatory Drugs Market size was valued at USD 15.58 billion in 2019 and is projected to reach USD 32.33 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period of 2024-2032.
The COVID-19 pandemic substantially impacted the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market. The pandemic disrupted worldwide supply chains, causing brief shortages. Simultaneously, expanded instances of COVID-19 caused irritation-associated signs, riding the demand for ache alleviation and anti inflammatory treatments, boosting the marketplace's recuperation as healthcare services normalized post-pandemic.
A first-rate trend inside the NSAIDs marketplace is the shift toward over the counter (OTC) formulations and the increasing adoption of topical NSAIDs. With customers who prefer self-medicine for slight pain and infection, the OTC segment is witnessing giant growth. Additionally, topical NSAIDs like gels and creams are gaining reputation due to their targeted action, reduced systemic aspect effects, and simplicity of utility. This trend reflects the rising client preference for safer, non-prescription pain comfort options and has triggered pharmaceutical agencies to enlarge their OTC product portfolios.
One key using thing for the NSAIDs marketplace is the growing occurrence of continual pain and inflammatory conditions, inclusive of arthritis and musculoskeletal disorders. With an getting old worldwide populace and a upward thrust in life-style-related fitness problems, there's a developing call for for powerful pain management solutions. NSAIDs, known for their efficacy in reducing irritation and ache, are regularly prescribed for these conditions. Their broad therapeutic packages, coupled with growing affected person recognition and the supply of diverse formulations, keep to force market growth.
Comprehensive Analysis of Non-steroidal Anti-Inflammatory Drugs Market
The Non-steroidal Anti-Inflammatory Drugs Market growth is rising at an exponential rate due to its marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated by disease indication, by route of administration, by distribution channel. By Disease Indication include Arthritis, Migraine, Ophthalmic Diseases, Others. By Route of Administration include Oral ,Parenteral .By Distribution Channel include Hospital Pharmacy, Retail Pharmacy, Online Pharmacy.
The North America location lead the Non-steroidal Anti-Inflammatory Drugs Market share percentage via benefitting a marketplace size of USD 6.86 billion Strategic presence of major manufacturers, rising prevalence of arthritis, and increased research are the factors for the dominant share of North America.
The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Google LLC (Alphabet, Inc.), Magic Leap, Inc., ReWalk Robotics, SAMSUNG, B-Temia, Panasonic Holdings Corporation, NVIDIA Corporation, Microsoft, Ekso Bionics, Vuzix,these market players provide a level-playing competitive landscape.
May 2019 - Perrigo Company p.C announced the FDA popularity of Abbreviated New Drug Application (ANDA) referencing to Voltaren Gel.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2016-2027
Base Year 2019
Forecast Period 2020-2027
Historical Period 2016-2018
Unit Value (USD billion)
By Disease Indication
Arthritis
Migraine
Ophthalmic Diseases
Others
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Geography
North America (the U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East& Africa (South Africa, GCC and Rest of Middle East & Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of Major Diseases – For Key Countries
- 4.2. Pipeline Analysis
- 4.3. New Product Launches
- 4.4. Key Industry Developments - Mergers, Acquisitions and Partnerships
- 4.5. Key Trends
- 5. Global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Disease Indication
- 5.2.1. Arthritis
- 5.2.2. Migraine
- 5.2.3. Ophthalmic Diseases
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By Route of Administration
- 5.3.1. Oral
- 5.3.2. Parenteral
- 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.4.1. Hospital Pharmacy
- 5.4.2. Retail Pharmacy
- 5.4.3. Online Pharmacy
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Disease Indication
- 6.2.1. Arthritis
- 6.2.2. Migraine
- 6.2.3. Ophthalmic Diseases
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast – By Route of Administration
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.4.1. Hospital Pharmacy
- 6.4.2. Retail Pharmacy
- 6.4.3. Online Pharmacy
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Disease Indication
- 7.2.1. Arthritis
- 7.2.2. Migraine
- 7.2.3. Ophthalmic Diseases
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast – By Route of Administration
- 7.3.1. Oral
- 7.3.2. Parenteral
- 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.4.1. Hospital Pharmacy
- 7.4.2. Retail Pharmacy
- 7.4.3. Online Pharmacy
- 7.5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Disease Indication
- 8.2.1. Arthritis
- 8.2.2. Migraine
- 8.2.3. Ophthalmic Diseases
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast – By Route of Administration
- 8.3.1. Oral
- 8.3.2. Parenteral
- 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.4.1. Hospital Pharmacy
- 8.4.2. Retail Pharmacy
- 8.4.3. Online Pharmacy
- 8.5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Disease Indication
- 9.2.1. Arthritis
- 9.2.2. Migraine
- 9.2.3. Ophthalmic Diseases
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast – By Route of Administration
- 9.3.1. Oral
- 9.3.2. Parenteral
- 9.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.4.1. Hospital Pharmacy
- 9.4.2. Retail Pharmacy
- 9.4.3. Online Pharmacy
- 9.5. Market Analysis, Insights and Forecast – By Countries/ Sub regions
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Analysis, Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Disease Indication
- 10.2.1. Arthritis
- 10.2.2. Migraine
- 10.2.3. Ophthalmic Diseases
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast – By Route of Administration
- 10.3.1. Oral
- 10.3.2. Parenteral
- 10.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.4.1. Hospital Pharmacy
- 10.4.2. Retail Pharmacy
- 10.4.3. Online Pharmacy
- 10.5. Market Analysis, Insights and Forecast – By Countries/ Sub region
- 10.5.1. South Africa
- 10.5.2. GCC
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2019)
- 11.3. Company Profiles (Overview, Product & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.3.1. GlaxoSmithKline plc
- 11.3.1.1. Overview,
- 11.3.1.2. Product & Services,
- 11.3.1.3. SWOT analysis,
- 11.3.1.4. Recent developments,
- 11.3.1.5. strategies,
- 11.3.1.6. financials (based on availability)
- 11.3.2. Pfizer Inc.
- 11.3.2.1. Overview,
- 11.3.2.2. Product & Services,
- 11.3.2.3. SWOT analysis,
- 11.3.2.4. Recent developments,
- 11.3.2.5. strategies,
- 11.3.2.6. financials (based on availability)
- 11.3.3. Johnson & Johnson Services, Inc.
- 11.3.3.1. Overview,
- 11.3.3.2. Product & Services,
- 11.3.3.3. SWOT analysis,
- 11.3.3.4. Recent developments,
- 11.3.3.5. strategies,
- 11.3.3.6. financials (based on availability)
- 11.3.4. Bayer AG
- 11.3.4.1. Overview,
- 11.3.4.2. Product & Services,
- 11.3.4.3. SWOT analysis,
- 11.3.4.4. Recent developments,
- 11.3.4.5. strategies,
- 11.3.4.6. financials (based on availability)
- 11.3.5. AstraZeneca
- 11.3.5.1. Overview,
- 11.3.5.2. Product & Services,
- 11.3.5.3. SWOT analysis,
- 11.3.5.4. Recent developments,
- 11.3.5.5. strategies,
- 11.3.5.6. financials (based on availability)
- 11.3.6. Boehringer Ingelheim International GmbH
- 11.3.6.1. Overview,
- 11.3.6.2. Product & Services,
- 11.3.6.3. SWOT analysis,
- 11.3.6.4. Recent developments,
- 11.3.6.5. strategies,
- 11.3.6.6. financials (based on availability)
- 11.3.7. Zyla Life Sciences
- 11.3.7.1. Overview,
- 11.3.7.2. Product & Services,
- 11.3.7.3. SWOT analysis,
- 11.3.7.4. Recent developments,
- 11.3.7.5. strategies,
- 11.3.7.6. financials (based on availability)
- 11.3.8. Horizon Therapeutics plc
- 11.3.8.1. Overview,
- 11.3.8.2. Product & Services,
- 11.3.8.3. SWOT analysis,
- 11.3.8.4. Recent developments,
- 11.3.8.5. strategies,
- 11.3.8.6. financials (based on availability)
- 11.3.9. Other Prominent Players
- 11.3.9.1. Overview,
- 11.3.9.2. Product & Services,
- 11.3.9.3. SWOT analysis,
- 11.3.9.4. Recent developments,
- 11.3.9.5. strategies,
- 11.3.9.6. financials (based on availability)
- 12. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook